Bower M, Parry P, Carter M, Lillington D M, Amess J, Lister T A, Evans G, Young B D
Molecular Genetics Laboratory, Centre for Human Genome Research, Salk Institute for Biological Studies, San Diego, CA.
Blood. 1994 Dec 1;84(11):3776-80.
Rearrangements of the human trithorax gene (MLL, HRX, Htrx-1, All-1) were studied by Southern blotting in blast cells stored at presentation from 65 adults with de novo acute myelomonocytic (AML-M4) and acute monocytic leukemia (AML-M5). MLL rearrangements were demonstrated in 15 (23%) cases, including eight patients in whom karyotype analysis had failed to detect abnormalities of chromosome band 11q23. The patients with MLL rearrangements did not differ significantly from those with germline configurations in terms of the sex and age of the patients, the presence of lymphadenopathy, hepatosplenomegaly, or central nervous system involvement, and the absolute blast count at diagnosis. Kaplan-Meier analysis of the treated patients demonstrated no difference in survival for patients with MLL rearrangements compared with those without rearrangements. Therefore, in contrast to infantile acute leukemia, in adults with AML-M4 and AML-M5, MLL rearrangements do not identify a subgroup of patients with different clinical features or prognosis.
通过Southern印迹法,对65例初发急性粒单核细胞白血病(AML-M4)和急性单核细胞白血病(AML-M5)成年患者就诊时保存的原始细胞中的人类三体胸苷基因(MLL、HRX、Htrx-1、All-1)重排进行了研究。在15例(23%)病例中证实存在MLL重排,其中8例患者的核型分析未能检测到11q23染色体带异常。MLL重排患者与种系构型患者在患者性别和年龄、是否存在淋巴结病、肝脾肿大或中枢神经系统受累以及诊断时的原始细胞绝对计数方面无显著差异。对接受治疗的患者进行的Kaplan-Meier分析表明,MLL重排患者与未重排患者的生存率无差异。因此,与婴儿急性白血病不同,在成人AML-M4和AML-M5中,MLL重排并不能识别出具有不同临床特征或预后的患者亚组。